Omeros reported $712K in Stock for its fiscal quarter ending in September of 2021.





Stock Change Date
Adma Biologics USD 196.67M 5.21M Sep/2025
Alnylam Pharmaceuticals USD 82.72M 7.34M Dec/2025
BioMarin Pharmaceutical USD 1.3B 83.29M Dec/2025
Cytokinetics USD 0 0 Dec/2023
Gilead Sciences USD 1.78B 40M Sep/2025
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Insmed USD 132.07M 11.1M Dec/2025
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
MacroGenics USD 8.75M 530K Sep/2025
Omeros USD 712K 266K Sep/2021
Pacira USD 152.86M 4.82M Dec/2025
Pfizer USD 11.47B 201M Sep/2025
Rockwell Medical USD 4.16M 885K Jun/2025
Sarepta Therapeutics USD 914.74M 162.42M Dec/2025
United Therapeutics USD 183.1M 6.6M Dec/2025
Vertex Pharmaceuticals USD 1.69B 60M Dec/2025